{
  "id": 16986338,
  "title": "Recommendations developed for management of hidradenitis suppurativa",
  "url": "https://urgent.news/2026/10/29/recommendations-developed-for-management-of-hidradenitis-suppurativa",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-29T01:00:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-hidradenitis-suppurativa.html"
  },
  "original_language": "en",
  "account": "Hidradenitis suppurativa (HS) management guidelines have been developed by the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation. The guidelines provide 37 evidence-based recommendations for treating HS. Strongly recommended interventions include adalimumab, bimekizumab, infliximab, secukinumab, and routine pain assessment. Conditional recommendations involve using topical therapies like clindamycin, resorcinol, and ruxolitinib, as well as systemic antibiotics such as oral doxycycline, tetracycline, clindamycin with rifampin, and intravenous ertapenem. Hormone therapy with spironolactone, short-term systemic corticosteroids, and upadacitinib are also conditionally recommended. Specific procedural interventions, tobacco cessation, supportive pain management, zinc supplementation, and vitamin D repletion are conditionally suggested as well. These guidelines establish an evidence-based standard of care for HS, ensuring patients, dermatologists, and payers have a shared roadmap for high-quality HS care.",
  "summary": "Evidence-based recommendations are presented for the management of hidradenitis suppurativa (HS) in guidelines of care issued by the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation and published online Oct. 20 in the Journal of the American Academy of Dermatology.",
  "key_points": [
    "37 evidence-based recommendations provided for treating HS.",
    "Strongly recommend adalimumab, bimekizumab, infliximab, secukinumab, and routine pain assessment."
  ],
  "editors_take": "Standardizing treatment protocols through these evidence-based recommendations provides clinicians and payers with a unified framework to ensure more consistent and high-quality care for patients living with this condition.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}